autologous human Schwann cells
autologous human Schwann cells is a biological therapy with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Autologous Human Schwann Cells in Peripheral Nerve Repair
Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair
The Safety of ahSC in Chronic SCI With Rehabilitation
Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair
Clinical Trials (6)
Autologous Human Schwann Cells in Peripheral Nerve Repair
Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair
The Safety of ahSC in Chronic SCI With Rehabilitation
Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair
Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6